Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

Seigo Minami, Yoshitaka Ogata, Shouichi Ihara, Suguru Yamamoto, Kiyoshi Komuta Department of Respiratory Medicine, Osaka Police Hospital, Osaka, Japan Background: Pulmonary adenocarcinoma, recently benefited by new cytotoxic and molecularly targeted drugs, has been classified by...

Full description

Bibliographic Details

Main Authors:	Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Format:	Artigo
Language:	Inglês
Published:	Dove Medical Press 2017-02-01
Series:	Lung Cancer: Targets and Therapy
Subjects:	adenocarcinoma non-small cell lung cancer first-line chemotherapy second-line chemotherapy third-line chemotherapy epidermal growth factor receptor wild-type
Online Access:	https://www.dovepress.com/trajectory-of-chemotherapy-for-patients-with-egfr-wild-type-advanced-p-peer-reviewed-article-LCTT
Tags:	Add Tag No Tags, Be the first to tag this record!